Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:48 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Diabetic Gastroparesis Study 05
NCT03786380 · Allergan · PHASE3 · terminated · last registry update 2021-12-15 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The Relamorelin program is being terminated solely based on a business decision.” | – | Registry record, Allergan |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against GHSR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-03-16Results posted on the registry: National Institute on Alcohol Abuse and Alcoholism (NIAAA), PF-05190457 (NCT02707055)
- 2022-03-16Also stopped (terminated): National Institute on Alcohol Abuse and Alcoholism (NIAAA), PF-05190457 (NCT02707055)
- 2022-02-03Results posted on the registry: M.D. Anderson Cancer Center, Anamorelin Hydrochloride (NCT03035409)
- 2021-12-22Results posted on the registry: Allergan, Placebo + Relamorelin (NCT03420781)
- 2021-12-22Also stopped (terminated): Allergan, Placebo + Relamorelin (NCT03420781)
- 2021-11-23Results posted on the registry: Allergan, Placebo + Relamorelin (NCT03383146)
- 2021-11-23Also stopped (terminated): Allergan, Placebo + Relamorelin (NCT03383146)
- 2021-08-06Results posted on the registry: Allergan, Placebo + Relamorelin (NCT03426345)
- 2021-08-06Also stopped (terminated): Allergan, Placebo + Relamorelin (NCT03426345)
- 2021-07-29Results posted on the registry: Allergan, Placebo + Relamorelin (NCT03285308)
- 2021-07-29Also stopped (terminated): Allergan, Placebo + Relamorelin (NCT03285308)
- 2021-03-08Phase 3 first posted: AEterna Zentaris, Macimorelin (NCT04786873)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision